人类骨髓增生异常综合征的骨髓基质微环境改变可调控疾病进展
该研究识别出人类骨髓中以CD271、CD146、CD106标记的间充质细胞亚群,其转录分析显示骨桥蛋白(SPP1)为最过表达基因。在小鼠MDS模型Vav驱动的Nup98-HoxD13中,微环境选择性敲除Spp1导致嵌合率升高、突变髓系负荷增加及贫血加重,提示Spp1过表达可限制疾病进展并保护宿主。
要点
- 人类骨髓CD271+CD146+CD106+间充质细胞亚群与小鼠MDS相关间充质细胞可比。
- 该亚群转录分析显示骨桥蛋白(SPP1)为最过表达基因。
- 小鼠MDS微环境敲除Spp1导致嵌合率升高、突变髓系负荷增加及贫血加重。
核心结论
- MDS患者骨髓特定间充质细胞亚群可发生分子改变。
- 微环境对异常克隆的适应包括Spp1过表达,可约束疾病适应性并可能限制进展。
- 恶性疾病相关的微环境改变也可保护宿主。
研究设计与样本
- 研究识别人类骨髓中以CD271、CD146、CD106表达标记的间充质细胞亚群,并与小鼠MDS相关间充质细胞比较。
- 对该亚群进行转录分析,并在小鼠MDS模型Vav驱动的Nup98-HoxD13中于微环境选择性敲除Spp1。
主要发现
- 该人类间充质细胞亚群与小鼠中间充质细胞可比,后者受扰动可导致MDS样综合征。
- 转录分析显示骨桥蛋白(SPP1)为该亚群中最过表达基因。
- 与野生型微环境对照相比,小鼠MDS模型微环境选择性敲除Spp1后嵌合率升高、突变髓系细胞负荷增加、贫血更明显。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myelodysplastic syndromes (MDSs) are a heterogenous group of diseases affecting the hematopoietic stem cell that are curable only by stem cell transplantation. Both hematopoietic cell intrinsic changes and extrinsic signals from the bone marrow (BM) niche seem to ultimately lead to MDS. Animal models of MDS indicate that alterations in specific mesenchymal progenitor subsets in the BM microenvironment can induce or select for abnormal hematopoietic cells. Here, we identify a subset of human BM mesenchymal cells marked by the expression of CD271, CD146, and CD106. This subset of human mesenchymal cells is comparable with mouse mesenchymal cells that, when perturbed, result in an MDS-like syndrome. Its transcriptional analysis identified Osteopontin (SPP1) as the most overexpressed gene. Selective depletion of Spp1 in the microenvironment of the mouse MDS model, Vav-driven Nup98-HoxD13, resulted in an accelerated progression as demonstrated by increased chimerism, higher mutant myeloid cell burden, and a more pronounced anemia when compared with that in wild-type microenvironment controls. These data indicate that molecular perturbations can occur in specific BM mesenchymal subsets of patients with MDS. However, the niche adaptations to dysplastic clones include Spp1 overexpression that can constrain disease fitness and potentially progression. Therefore, niche changes with malignant disease can also serve to protect the host.
引用
- Kfoury YS, Ji F, Jain E, et al. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression. Blood Adv. 2023. PMID: 37450380. doi:10.1182/bloodadvances.2022008268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。